Navigation Links
Texcel Highlights Medical Device Development & Manufacturing Solutions at MD&M West, booth 314
Date:2/4/2009

EAST LONGMEADOW, Mass., Feb. 4 /PRNewswire/ -- Texcel's custom medical device development and manufacturing solutions helps companies around the world accelerate the commercialization of their surgical, interventional, and implantable medical device technologies. Texcel will highlight its full array of services and technologies at the MD&M West Expo, February 10-12, 2009, in exposition booth # 314.

Texcel provides the manufacturing infrastructure and expertise for a wide range of product applications -- from endoscopic surgical instrumentation and spinal/orthopedic implants to total artificial hearts and neurostimulators.

Texcel's specialized services and full medical device solutions include device design, development history file management, quality and regulatory assistance, process validation, along with general manufacturing, electronic testing, laser welding, and clean-room processing for a wide range of product applications.

Texcel, with more than 20 years of experience assisting companies execute increasingly sophisticated designs through reliable manufacturing, has particular expertise in five key areas:

  • Orthopedics, including products ranging from metal bone fastening devices to novel new materials;
  • Cardiac Assist, with expertise helping industry pioneers assemble and produce many types of cardiac assist devices;
  • Active Implantables, including a wide range of metal and non-metal biocompatible materials as well as dynamic mechanical and electrical features;
  • Combination Products, combining strong internal development and manufacturing capabilities with partners specializing in pharmaceuticals.
  • General Instrumentation, including a wide array of interventional products from durable medical equipment components to disposable catheter devices, and a full range of materials and assembly methods.

"By combining our comprehensive, highly integrated suite of capabilities and state of the art production facility into a single, seamless solution, we manage all the concerns of development and manufacturing process for our clients. We thus empower our clients to focus other priorities, such as developing new markets and therapies based on their proprietary technologies," said Keith Checca, Director of Business Development, Texcel, (www.texcelmedical.com).

The company is staffed with over fifty (50) talented, experienced, and passionate medical device industry employees within an ISO 13485 and ISO 9001 environment.

Based in East Longmeadow, Massachusetts, Texcel works with companies around the world.

For more information, visit Texcel at MD&M West 2009 in booth # 314; online visit www.texcelmedical.com, or call 413-525-5700.


'/>"/>
SOURCE Texcel
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
2. Highlights of Economic and Business Growth in the Tampa Bay Region
3. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Highlights of Economic and Business Growth in the Tampa Bay Region
6. Highlights of Economic and Business Growth in the Tampa Bay Region
7. Oncothyreon highlights corporate and clinical objectives for 2008
8. CyberKnife Users Meeting Highlights Major Clinical Data Milestones and Emerging Trends
9. National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights
10. MEDEA+ Noblanc award highlights improvements in microelectronics
11. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... N.J. , Dec. 8, 2016 Soligenix, ... biopharmaceutical company focused on developing and commercializing products to ... need, announced today that it will be hosting an ... am ET on the origins of innate defense regulators ... a review of oral mucositis and the recently announced ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. Ltd. ... KRW (US $18.9M) Series A financing. This financing round ... Tech Venture and SNU Bio Angel. This new funding ... billion KRW (US $27.7M) since its founding in 2015. ... bolster the development and commercialization of its immuno-oncology programs, ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
(Date:12/7/2016)... Dec. 7, 2016 Neogen Corporation (NASDAQ: ... Dan Kephart as its chief science officer ... assume his responsibilities at Neogen effective Jan. 1. ... for the agribusiness unit of Thermo Fisher Scientific, as ... Life Technologies. His extensive industry experience also includes the ...
Breaking Biology Technology:
(Date:11/29/2016)... 29, 2016   Neurotechnology , a ... recognition technologies, today released FingerCell 3.0, a ... solutions that run on low-power, low-memory microcontrollers. ... less than 128KB of memory, enabling it ... have limited on-board resources, such as: mobile ...
(Date:11/22/2016)... Minn. , Nov. 22, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... Medical LiveWire Healthcare and Life Sciences Awards ... award caps off an unprecedented year of recognition and ... trials for over 15 years. iMedNet ...
(Date:11/16/2016)... 2016 Sensory Inc ., a ... for consumer electronics, and VeriTran , a ... industry, today announced a global partnership that will ... authenticate users of mobile banking and mobile payments ... software which requires no specialized biometric scanners, yet ...
Breaking Biology News(10 mins):